Pathik Gandotra of Dron Capital feels Ranbaxy Labs can also give a very high return, but it is extremely risky, he adds.
first published: Oct 5, 2013 03:24 pm
A collection of the most-viewed Moneycontrol videos.

PM Modi Condemns Attacks on Qatar, Reaffirms Peace and Stability

“Too Late” for Talks: Trump Says Iran Military, Leadership Gone

Live: Sensex, Nifty drop over 1% amid Iran-US tensions; India VIX soars | Closing Bell
‘Pharma Has A Great Future in India Given Our Quality Of Talent & Our Low Manufacturing Cost’: Ajay Piramal
You are already a Moneycontrol Pro user.


